S&P 500   5,123.41
DOW   37,983.24
QQQ   441.74
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks
S&P 500   5,123.41
DOW   37,983.24
QQQ   441.74
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks
S&P 500   5,123.41
DOW   37,983.24
QQQ   441.74
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks
S&P 500   5,123.41
DOW   37,983.24
QQQ   441.74
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks

hVIVO (HVO) Competitors

GBX 28.16
-0.64 (-2.22%)
(As of 01:54 PM ET)

HVO vs. OXB, AVCT, BVXP, 4BB, FUM, SCLP, FARN, ETX, POLB, and PRTC

Should you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Oxford Biomedica (OXB), Avacta Group (AVCT), Bioventix (BVXP), 4basebio (4BB), Futura Medical (FUM), Scancell (SCLP), Faron Pharmaceuticals Oy (FARN), e-therapeutics (ETX), Poolbeg Pharma (POLB), and PureTech Health (PRTC). These companies are all part of the "biotechnology" industry.

hVIVO vs.

Oxford Biomedica (LON:OXB) and hVIVO (LON:HVO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, profitability and community ranking.

Oxford Biomedica received 235 more outperform votes than hVIVO when rated by MarketBeat users. However, 69.89% of users gave hVIVO an outperform vote while only 66.79% of users gave Oxford Biomedica an outperform vote.

CompanyUnderperformOutperform
Oxford BiomedicaOutperform Votes
358
66.79%
Underperform Votes
178
33.21%
hVIVOOutperform Votes
123
69.89%
Underperform Votes
53
30.11%

Oxford Biomedica currently has a consensus price target of GBX 498.75, suggesting a potential upside of 150.69%. Given hVIVO's higher probable upside, research analysts plainly believe Oxford Biomedica is more favorable than hVIVO.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oxford Biomedica
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
hVIVO
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, hVIVO had 6 more articles in the media than Oxford Biomedica. MarketBeat recorded 7 mentions for hVIVO and 1 mentions for Oxford Biomedica. hVIVO's average media sentiment score of 0.67 beat Oxford Biomedica's score of 0.57 indicating that Oxford Biomedica is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oxford Biomedica
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
hVIVO
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

hVIVO has a net margin of 4.75% compared to hVIVO's net margin of -51.78%. Oxford Biomedica's return on equity of 13.55% beat hVIVO's return on equity.

Company Net Margins Return on Equity Return on Assets
Oxford Biomedica-51.78% -30.64% -12.05%
hVIVO 4.75%13.55%11.65%

Oxford Biomedica has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, hVIVO has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500.

58.1% of Oxford Biomedica shares are held by institutional investors. Comparatively, 14.0% of hVIVO shares are held by institutional investors. 16.2% of Oxford Biomedica shares are held by insiders. Comparatively, 39.2% of hVIVO shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

hVIVO has lower revenue, but higher earnings than Oxford Biomedica.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxford Biomedica£119.02M1.67-£61.63M-£0.64-310.86
hVIVO£60.48M3.21£2.88MN/AN/A

Summary

hVIVO beats Oxford Biomedica on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HVO vs. The Competition

MetrichVIVOBiotechnology IndustryMedical SectorLON Exchange
Market Cap£194.25M£371.53M£4.68B£1.39B
Dividend YieldN/A3.48%5.42%11.99%
P/E Ratio-1.00218.82243.971,735.48
Price / Sales3.2112,391.522,387.35324,397.95
Price / Cash4.9412.0734.0932.83
Price / Book9.525.434.572.53
Net Income£2.88M-£37.60M£98.74M£179.61M
7 Day Performance-2.48%8.20%109.74%4.75%
1 Month Performance-0.17%7.09%115.07%3.79%
1 Year Performance78.44%62.67%138.27%18.84%

hVIVO Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OXB
Oxford Biomedica
1.6292 of 5 stars
GBX 196
-2.5%
GBX 498.75
+154.5%
-54.6%£195.92M£119.02M-306.25891
AVCT
Avacta Group
0 of 5 stars
GBX 50.25
+1.0%
N/A-62.8%£176.13M£16.02M-314.06120
BVXP
Bioventix
0 of 5 stars
GBX 4,550
+2.2%
N/A+17.9%£237.51M£12.82M2,879.7512
4BB
4basebio
0 of 5 stars
GBX 945
-1.6%
N/A+61.9%£121.05M£311,000.00-1,852.9478Gap Up
FUM
Futura Medical
0 of 5 stars
GBX 40
-1.2%
N/A-16.7%£120.58M£1.70M-2,000.0012Negative News
SCLP
Scancell
0 of 5 stars
GBX 10.50
+2.4%
N/A-49.5%£97.42M£5.27M-1,050.0051Gap Down
High Trading Volume
FARN
Faron Pharmaceuticals Oy
0 of 5 stars
GBX 138
+0.4%
N/A-59.1%£94.96M£-725,000.00-328.5740Gap Up
ETX
e-therapeutics
0 of 5 stars
GBX 10.75
-2.3%
N/A-19.9%£62.82M£295,000.00-537.5034Gap Up
POLB
Poolbeg Pharma
0 of 5 stars
GBX 10.20
+3.6%
N/A+32.4%£51MN/A-1,020.0012
PRTC
PureTech Health
0 of 5 stars
GBX 219.50
-1.3%
N/A-1.4%£592.54M£11.74M-1,688.46300

Related Companies and Tools

This page (LON:HVO) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners